Our Vision & Strategy

Our Vision:

To bring individualized cancer and other therapies to market.

Our Strategy:

Build and leverage all building blocks of immunotherapy under one roof: Our technology platforms and clinical pipeline are based on 20 years of research and development.

Build a fully integrated biotech company spanning research through clinical development and manufacturing to sales and marketing.

Enter licensing, co-commercialization and co-development agreements and advance a unique go-to-market strategy.

BioNTech’s -product-to-market offering of truly individualized cancer treatments will come through its mRNA technology platform.

Lead product: IVAC® (Individualized Vaccine Against Cancer) targets cancer mutations or “neoantigens” and could therefore be universally applicable across cancer types.

As a research-driven biotechnology company, we set out to achieve both scientific and commercial success. In our efforts to achieve this, full legal compliance and a strong sense of ethical responsibility underpin everything we do. Operating with integrity is non-negotiable for BioNTech. This understanding is anchored in our Code of Conduct.

Our corporate values represent what we consider to be important and what we would like to stand for as a company. They serve as a practical orientation and shape our corporate identity.

BioNTech stands for visionary thinking and pioneering spirit – with our work we want to revolutionize cancer immunotherapy.

Innovation and innovative thinking in all areas of work therefor is the cornerstone of our success.

Passion and enthusiasm guide our daily work and everything we do.

Unidarity* is the basis to achieve our ambitious goals successfully together – with our employees as well as in interaction with our partners.

* Unidarity is a neologism derived from unity and solidarity.